Vimarsana
Biggest News Aggregation in the World

Specific Gene Editing System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Specific Gene Editing System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Specific Gene Editing System Today - Breaking & Trending Today

Poseida Therapeutics Announces Virtual 2024 Annual Meeting Of Stockholders - Vimarsana News

Poseida Therapeutics Announces Virtual 2024 Annual Meeting Of Stockholders

SAN DIEGO, June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX ), a clinical-stage allogeneic cell therapy and genetic medi

Source: menafn.com
Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition - Vimarsana News

Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition

SAN DIEGO - Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the acceptance...

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences - Vimarsana News

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...

Poseida Therapeutics Announces Leadership Appointments - Vimarsana News

Poseida Therapeutics Announces Leadership Appointments

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...

Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting - Vimarsana News

Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nadsaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...